GoodRx Holdings (GDRX) Research & Development (2019 - 2026)
GoodRx Holdings (GDRX) posted Research & Development of $30.2 million for Q1 2026, up 4.28% sequentially from $28.9 million in Q4 2025, and down 3.1% YoY from $31.1 million in Q1 2025.
GoodRx Holdings (GDRX) Research & Development (2019 - 2026) Analysis & Trends
GoodRx Holdings has reported Research & Development for 8 years, with the latest figure at $30.2 million in Q1 2026.
- Quarterly Research & Development fell 3.1% year-over-year to $30.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.6 million (up 3219.5% YoY) and the FY2025 annual result came in at $121.0 million, down 2.2% from the prior year.
- Research & Development climbed to $30.2 million in Q1 2026 per GDRX's latest filing, from $28.9 million in the prior quarter.
- Over five years, Research & Development peaked at $94.3 million in Q2 2022 and troughed at -$149.5 million in Q4 2024.
- A 5-year average of $47.6 million and a median of $35.9 million in 2022 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2024: Research & Development soared 255.31% in 2022, then sank 566.83% in 2024.
- Over 5 years, Research & Development stood at $84.1 million in 2022, then plunged by 61.92% to $32.0 million in 2023, then tumbled by 566.83% to -$149.5 million in 2024, then soared by 119.35% to $28.9 million in 2025, then gained by 4.28% to $30.2 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $30.2 million, $28.9 million, and $83.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 56.79 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 81.41 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 50.38 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 45.05 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 30.58 Mn |
| 10 | GoodRx Holdings | 1.27 Bn | 972.56 Mn | 179.41 Mn | 81.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.99 Mn |
| Mar 31, 2026 | 30.18 Mn |
| Dec 31, 2025 | 28.94 Mn |
| Sep 30, 2025 | 83.53 Mn |
| Jun 30, 2025 | 29.93 Mn |
| Mar 31, 2025 | 31.14 Mn |
| Dec 31, 2024 | -149.54 Mn |
| Sep 30, 2024 | 30.14 Mn |
| Jun 30, 2024 | 93.45 Mn |
| Mar 31, 2024 | 89.96 Mn |
| Dec 31, 2023 | 32.03 Mn |
| Sep 30, 2023 | 91.62 Mn |
| Jun 30, 2023 | 31.29 Mn |
| Mar 31, 2023 | 78.52 Mn |
| Dec 31, 2022 | 84.13 Mn |
| Sep 30, 2022 | 35.92 Mn |
| Jun 30, 2022 | 94.34 Mn |
| Mar 31, 2022 | 92.95 Mn |
| Dec 31, 2021 | 279.42 Mn |
| Sep 30, 2021 | 95.65 Mn |